Establishment Labs Holdings Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Establishment Labs Holdings Inc. on April 29, 2019, covering events that occurred on April 25, 2019. The company is incorporated in the British Virgin Islands and is designated as an emerging growth company.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The report focuses exclusively on corporate governance and executive compensation matters.
Material Changes
The primary material event reported is the approval of stock option grants to executive officers under the company's 2018 Equity Incentive Plan. The exercise price for these options is set at $25.25 per share, reflecting the closing stock price on April 25, 2019.
- Juan Jose Chacon-Quiros (CEO): Granted 80,000 options.
- Salvador Dada (COO): Granted 35,000 options.
- Roberto de Mezerville (CTO): Granted 25,000 options.
- Eddie de Oliveria (VP Sales Brazil): Granted 36,000 time-based options and 6,000 performance-based options.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on financial outlook, or discussion of general risks. However, it notes specific contingencies regarding the vesting of the performance-based options granted to Eddie de Oliveria, which are contingent upon achieving certain revenue targets for 2019.
Investor Verification Checklist
- Verify the vesting commencement dates: January 1, 2020, for the CEO, COO, and CTO; April 25, 2019, for the time-based portion of the VP of Sales' grant.
- Confirm the specific revenue targets required for the 6,000 performance-based options granted to Eddie de Oliveria to vest by January 31, 2020.
- Review the full terms of the 2018 Equity Incentive Plan to understand dilution implications.